课题基金 / 基金详情

Developing novel GluN2A-containing NMDAR-based stroke therapies

Developing novel GluN2A-containing NMDAR-based stroke therapies
开发新型基于 NMDAR 的 GluN2A 中风疗法
批准号：
342375
负责人：
Wang Yu Tian
金额：
$69.62万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2021-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=342375&lang=en
关键词：
Neuroscience Research Neurotransmitters Stroke

项目摘要

项目成果

Wang Yu Tian的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Stroke is the third leading cause of death in North America, the leading cause of disability, and it represents a huge socioeconomic stress. Stroke is a sudden loss of blood supply to brain that occurs when the blood supply to a specific part of the brain
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Physiological and pathological regulation of GABAA receptor functions
  • 批准号：
    480042
  • 项目类别：
    Operating Grants
  • 资助金额：
    $68.83万
  • 财政年份：
    2023
  • 负责人：
    Wang Yu Tian
  • 依托单位：
    University of British Columbia
Regulation of postsynaptic expression and function of GABA-A receptors
Investigation into molecular mechanisms and physiological roles of activity-dependent AMPAR trafficking
Investigation into the molecular mechanisms of AMPAR trafficking following primary blast-induced mTBI
海外基金